Nektar Therapeutics
NKTR
#5686
Rank
HK$9.00 B
Marketcap
HK$442.70
Share price
-1.37%
Change (1 day)
275.60%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$33.12

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$32.91. In 2024 the company made an earnings per share (EPS) of -HK$27.23 an increase over its 2023 EPS that were of -HK$170.39.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$33.1221.62%
2024-HK$27.23-84.02%
2023-HK$170.39-25.89%
2022-HK$229.91-31.12%
2021-HK$333.7714.86%
2020-HK$290.59-1.19%
2019-HK$294.10-163.96%
2018HK$459.82-725.4%
2017-HK$73.52-42.73%
2016-HK$128.3783.33%
2015-HK$70.0239.53%
2014-HK$50.18-69.29%
2013-HK$163.39-6.67%
2012-HK$175.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$101.38-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.08-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
HK$0.07780-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.61-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-HK$5.13-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.11-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
HK$81.22-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA